Emerging as a significant breakthrough in the struggle against obesity, the drug is capturing considerable buzz. This treatment combines effects of two recognized GLP-1 receptor agonists, dulaglutide , and an new glucose-dependent hormonal component. Initial patient results have demonstrated substantial weight loss in patients with a high BMI , per